Forbion BioEconomy Fund I Reaches Important Financial Milestone
Forbion, a prominent player in the life sciences venture capital landscape, has announced a remarkable achievement with its Forbion BioEconomy Fund I hitting the hard cap of €200 million. This milestone follows the fund's initial closing in 2024 and marks a significant advancement in attracting investors interested in sustainable biotechnology solutions.
Investment Focus on Planetary Health
The primary goal of Forbion BioEconomy Fund I is to provide investments that bridge the gap between biotechnology and planetary health. By doing so, Forbion hopes to support the development of technologies that contribute towards decarbonizing various industries as part of a broader strategy to foster sustainability.
Strong Institutional Backing for the Fund
Launched with an initial target of €150 million, the fund garnered extensive support from institutional investors based in Europe and North America. This includes notable organizations such as KfW Capital, Novo Holdings, and ABN AMRO Bank, all of which are keen on sustainability-focused investments.
Portfolio Companies Making an Impact
Throughout its focus sectors—Food, Agriculture, Materials, and Environmental Technologies—the fund has successfully invested in five portfolio companies that are actively working to create transformative and sustainable solutions. These companies showcase the innovative spirit Forbion is promoting and include:
- eeden – A company advancing textile-to-textile recycling through green chemistry depolymerisation technologies.
- Genomines – Utilizing plant biotechnology to extract valuable metals sustainably.
- SOLASTA Bio – Developing bio-safe and effective alternatives to traditional pesticides using novel peptides.
- Novameat – Pioneering the transition to plant-based proteins with scalable and clean protein cuts.
- PACT – Leveraging a biomaterial platform for high-performance collagen-based coating solutions in textiles.
Biotechnology’s Role in Addressing Global Challenges
Investment leaders, including Alexander Hoffmann and Joy Faucher from Forbion, highlight a shift in investor perspectives regarding climate change and industrial innovation. With a growing emphasis on life science solutions, they see biotechnology expanding its reach beyond health care to tackle global challenges related to food production, resource efficiency, and materials sustainability.
The Evolution of Capital Investment
As capital flows shift from software to science, the Forbion team expresses excitement about furthering a portfolio that emphasizes biological and chemical technologies. This pivot aims to help develop commercially viable solutions essential for combating climate change and supporting the environment.
Future Prospects of Forbion BioEconomy Fund I
Looking ahead, the Forbion BioEconomy Fund I aims to develop a portfolio consisting of 12 to 14 investments predominantly focused on North American and European sustainable innovations. The fund's target is to support businesses that present cost-effective, scalable, and biology-based solutions ready to compete with existing products.
Potential Market Impact
With the backing of institutional investors and the innovative solutions from its portfolio companies, Forbion is poised to capitalize on the emerging market for biotech-enabled alternatives. This rapidly growing sector is projected to represent a significant commercial opportunity, estimated in the trillions over the next decade.
About Forbion and Its Commitments
Founded in the heart of Europe, Forbion focuses on making impactful contributions to both human health and planetary health sectors. With approximately €5 billion in assets under management, Forbion has established a solid reputation through over 130 investments and continues to strive towards responsible investment practices.
Connecting with Forbion
For more information about Forbion and its investment strategies, please contact:
Forbion Communications
Email: laura.asbjornsen@forbion.com
Head of Marketing & Communications
Frequently Asked Questions
What is the Forbion BioEconomy Fund I?
The Forbion BioEconomy Fund I is a venture capital fund focusing on investments in biotechnology aimed at enhancing sustainability and planetary health.
What sectors does the fund focus on?
The fund primarily focuses on Food, Agriculture, Materials, and Environmental Technologies sectors.
Who are some of the portfolio companies?
Portfolio companies include eeden, Genomines, SOLASTA Bio, Novameat, and PACT, all advancing sustainable solutions.
What is the overall investment goal of the fund?
The fund aims to support 12 to 14 companies that offer scalable, cost-effective biotechnology-based solutions.
How much has the fund raised?
The Forbion BioEconomy Fund I has successfully raised €200 million, reaching its hard cap.
